CJC-1295 with DAC

Description

Overview

CJC-1295 with DAC is engineered as a long-acting analog of growth hormone–releasing hormone (GHRH) and is commonly used as a research tool to evaluate sustained receptor engagement and downstream signaling persistence. The inclusion of the Drug Affinity Complex allows researchers to investigate how albumin-binding modifications influence peptide stability, circulation time, and signaling duration under controlled laboratory conditions.

Within research peptides workflows, CJC-1295 with DAC is studied to better understand how structural enhancements affect peptide kinetics rather than immediate or acute biological responses.

Researchers may buy CJC-1295 with DAC online for non-clinical experimentation requiring reproducible peptide performance across extended observation periods.

Research Applications

In laboratory environments, CJC-1295 with DAC is utilized for exploratory and comparative research, including:

• Examination of GHRH-related signaling pathways in controlled in-vitro systems
• Analysis of extended peptide activity resulting from albumin-binding modifications
• Studies focused on peptide persistence and degradation resistance
• Comparative research on modified vs. unmodified peptide behavior
• Experimental timing and signaling-duration modeling in cellular and animal research models

These applications are conducted solely for research and educational purposes and do not imply therapeutic or performance-related outcomes.

Purchase & Use

CJC-1295 with DAC 5 mg is available to order online as a research-use-only chemical for qualified laboratories, academic institutions, and educational research facilities.

Research References (For Context Only)

• Teichman SL et al., 2006
• Alba M et al., 2006
• Sackmann-Sala L et al., 2009